vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.6倍（$786.9M vs $487.7M），RANGE RESOURCES CORP净利率更高（22.8% vs -10.1%，领先32.9%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 18.0%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 14.6%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
CLOV vs RRC — 直观对比
营收规模更大
RRC
是对方的1.6倍
$487.7M
营收增速更快
CLOV
高出26.8%
18.0%
净利率更高
RRC
高出32.9%
-10.1%
两年增速更快
CLOV
近两年复合增速
14.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $786.9M |
| 净利润 | $-49.3M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | -10.1% | — |
| 净利率 | -10.1% | 22.8% |
| 营收同比 | 44.7% | 18.0% |
| 净利润同比 | -123.2% | 88.8% |
| 每股收益（稀释后） | — | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVRRC
| Q4 25 | $487.7M | $786.9M | ||
| Q3 25 | $496.6M | $655.3M | ||
| Q2 25 | $477.6M | $699.6M | ||
| Q1 25 | $462.3M | $846.3M | ||
| Q4 24 | $337.0M | $667.0M | ||
| Q3 24 | $331.0M | $567.9M | ||
| Q2 24 | $356.3M | $513.2M | ||
| Q1 24 | $346.9M | $598.8M |
净利润CLOVRRC
| Q4 25 | $-49.3M | $179.1M | ||
| Q3 25 | $-24.4M | $144.3M | ||
| Q2 25 | $-10.6M | $237.6M | ||
| Q1 25 | $-1.3M | $97.1M | ||
| Q4 24 | $-22.1M | $94.8M | ||
| Q3 24 | $-9.2M | $50.7M | ||
| Q2 24 | $7.4M | $28.7M | ||
| Q1 24 | $-19.2M | $92.1M |
毛利率CLOVRRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | 24.5% | 94.3% | ||
| Q2 24 | 30.3% | 93.4% | ||
| Q1 24 | 23.6% | 94.7% |
营业利润率CLOVRRC
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | — | ||
| Q2 25 | -2.2% | — | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | -6.5% | — |
净利率CLOVRRC
| Q4 25 | -10.1% | 22.8% | ||
| Q3 25 | -4.9% | 22.0% | ||
| Q2 25 | -2.2% | 34.0% | ||
| Q1 25 | -0.3% | 11.5% | ||
| Q4 24 | -6.6% | 14.2% | ||
| Q3 24 | -2.8% | 8.9% | ||
| Q2 24 | 2.1% | 5.6% | ||
| Q1 24 | -5.5% | 15.4% |
每股收益（稀释后）CLOVRRC
| Q4 25 | — | $0.75 | ||
| Q3 25 | — | $0.60 | ||
| Q2 25 | — | $0.99 | ||
| Q1 25 | — | $0.40 | ||
| Q4 24 | — | $0.38 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $308.7M | $4.3B |
| 总资产 | $541.0M | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资CLOVRRC
| Q4 25 | $78.3M | $204.0K | ||
| Q3 25 | — | $175.0K | ||
| Q2 25 | — | $134.0K | ||
| Q1 25 | — | $344.6M | ||
| Q4 24 | $194.5M | $304.5M | ||
| Q3 24 | $288.0M | $277.4M | ||
| Q2 24 | $254.8M | $251.1M | ||
| Q1 24 | $208.3M | $343.1M |
总债务CLOVRRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益CLOVRRC
| Q4 25 | $308.7M | $4.3B | ||
| Q3 25 | $340.9M | $4.2B | ||
| Q2 25 | $344.2M | $4.1B | ||
| Q1 25 | $336.1M | $3.9B | ||
| Q4 24 | $341.1M | $3.9B | ||
| Q3 24 | $342.2M | $3.9B | ||
| Q2 24 | $324.9M | $3.9B | ||
| Q1 24 | $292.5M | $3.8B |
总资产CLOVRRC
| Q4 25 | $541.0M | $7.4B | ||
| Q3 25 | $559.7M | $7.2B | ||
| Q2 25 | $575.0M | $7.1B | ||
| Q1 25 | $583.7M | $7.4B | ||
| Q4 24 | $580.7M | $7.3B | ||
| Q3 24 | $653.0M | $7.2B | ||
| Q2 24 | $674.2M | $7.3B | ||
| Q1 24 | $671.8M | $7.4B |
负债/权益比CLOVRRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | — |
| 自由现金流率自由现金流/营收 | -14.1% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVRRC
| Q4 25 | $-66.9M | $257.5M | ||
| Q3 25 | $12.1M | $247.5M | ||
| Q2 25 | $5.4M | $336.2M | ||
| Q1 25 | $-16.3M | $330.1M | ||
| Q4 24 | $34.8M | $217.9M | ||
| Q3 24 | $50.0M | $245.9M | ||
| Q2 24 | $44.8M | $148.8M | ||
| Q1 24 | $25.9M | $331.9M |
自由现金流CLOVRRC
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | — | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $49.6M | — | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | — |
自由现金流率CLOVRRC
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | — |
资本支出强度CLOVRRC
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率CLOVRRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | 6.04× | 5.18× | ||
| Q1 24 | — | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
